Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$17.5 - $21.35 $824,950 - $1.01 Million
-47,140 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$17.75 - $25.39 $11,040 - $15,792
-622 Reduced 1.3%
47,140 $931,000
Q2 2021

Aug 13, 2021

BUY
$21.74 - $25.28 $224,248 - $260,763
10,315 Added 27.55%
47,762 $1.13 Million
Q1 2021

May 13, 2021

BUY
$19.25 - $26.1 $4,254 - $5,768
221 Added 0.59%
37,447 $887,000
Q4 2020

Feb 12, 2021

BUY
$17.83 - $22.29 $16,760 - $20,952
940 Added 2.59%
37,226 $746,000
Q3 2020

Nov 12, 2020

SELL
$15.78 - $20.82 $3,708 - $4,892
-235 Reduced 0.64%
36,286 $755,000
Q2 2020

Aug 12, 2020

BUY
$15.49 - $23.51 $4,631 - $7,029
299 Added 0.83%
36,521 $639,000
Q1 2020

May 06, 2020

BUY
$13.89 - $25.45 $14,403 - $26,391
1,037 Added 2.95%
36,222 $592,000
Q4 2019

Feb 12, 2020

BUY
$10.7 - $22.24 $376,479 - $782,514
35,185 New
35,185 $724,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.02B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Renaissance Group LLC Portfolio

Follow Renaissance Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Group LLC with notifications on news.